Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 6/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | NT5E | P21589 | 1/20 | 0.54 |
| ▸ | GSK3A | P49840 | 2/20 | 0.53 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.53 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.53 |
| ▸ | PNP | P00491 | 1/20 | 0.51 |
| ▸ | TGM2 | P21980 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.51 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.49 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26208189 | 0.90 | HPGD (0.58) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL2994000 | 0.89 | HPGD (0.68) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL26211540 | 0.89 | HINT1 (0.57) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL20248685 | 0.89 | HPGD (0.64) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL25711664 | 0.89 | HPGD (0.64) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL17198349 | 0.89 | HPGD (0.64) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL26622897 | 0.89 | HINT1 (0.61) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL17198483 | 0.87 | HPGD (0.61) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL1738428 | 0.86 | HPGD (0.60) | HINT1HPGDNT5EGSK3ARPS6KA3 | |
| SCHEMBL1738430 | 0.86 | HPGD (0.60) | HINT1HPGDNT5EGSK3ARPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023159930-A1 | COMPOUND FOR RNA CAPPING AND APPLICATION OF COMPOUND | 广州市恒诺康医药科技有限公司 | 2023-08-31 | — | — | WO | disclosed |